BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31395443)

  • 1. Building evidence and measuring clinical outcomes for genomic medicine.
    Peterson JF; Roden DM; Orlando LA; Ramirez AH; Mensah GA; Williams MS
    Lancet; 2019 Aug; 394(10198):604-610. PubMed ID: 31395443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    Mack SC; Northcott PA
    J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genomic medicine].
    Nielsen FC
    Ugeskr Laeger; 2019 Apr; 181(7A):. PubMed ID: 30950375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward clinical genomics in everyday medicine: perspectives and recommendations.
    Delaney SK; Hultner ML; Jacob HJ; Ledbetter DH; McCarthy JJ; Ball M; Beckman KB; Belmont JW; Bloss CS; Christman MF; Cosgrove A; Damiani SA; Danis T; Delledonne M; Dougherty MJ; Dudley JT; Faucett WA; Friedman JR; Haase DH; Hays TS; Heilsberg S; Huber J; Kaminsky L; Ledbetter N; Lee WH; Levin E; Libiger O; Linderman M; Love RL; Magnus DC; Martland A; McClure SL; Megill SE; Messier H; Nussbaum RL; Palaniappan L; Patay BA; Popovich BW; Quackenbush J; Savant MJ; Su MM; Terry SF; Tucker S; Wong WT; Green RC
    Expert Rev Mol Diagn; 2016; 16(5):521-32. PubMed ID: 26810587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
    Sheikine Y; Kuo FC; Lindeman NI
    J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput sequencing technologies.
    Reuter JA; Spacek DV; Snyder MP
    Mol Cell; 2015 May; 58(4):586-97. PubMed ID: 26000844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Applications of Next-Generation Sequencing.
    Rebollar-Vega RG; Arriaga-Canon C; de la Rosa-Velázquez IA
    Rev Invest Clin; 2018; 70(4):153-157. PubMed ID: 30067721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next-generation sequencing and empowering personalised cancer medicine.
    McDermott U
    Drug Discov Today; 2015 Dec; 20(12):1470-5. PubMed ID: 26494142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine.
    Ipe J; Swart M; Burgess KS; Skaar TC
    Clin Transl Sci; 2017 Mar; 10(2):67-77. PubMed ID: 28213901
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing the genomic revolution in cancer diagnostics.
    Nguyen D; Gocke CD
    Virchows Arch; 2017 Aug; 471(2):175-194. PubMed ID: 28639053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving health care through personal genomics.
    Rehm HL
    Nat Rev Genet; 2017 Apr; 18(4):259-267. PubMed ID: 28138143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
    Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
    Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating personalized genomic medicine into clinical practice: evidence, values, and health policy.
    Bombard Y
    Genome; 2015 Dec; 58(12):491-7. PubMed ID: 26577841
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.